1. Home
  2. PMCB vs LIQT Comparison

PMCB vs LIQT Comparison

Compare PMCB & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.46

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

HOLD

Current Price

$0.59

Market Cap

18.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
LIQT
Founded
1996
2004
Country
United States
Denmark
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
18.8M
IPO Year
2001
2011

Fundamental Metrics

Financial Performance
Metric
PMCB
LIQT
Price
$0.46
$0.59
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $4.30
AVG Volume (30 Days)
★ 302.6K
100.8K
Earning Date
03-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$42.12
Revenue Next Year
N/A
$63.48
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.52
52 Week High
$1.51
$3.35

Technical Indicators

Market Signals
Indicator
PMCB
LIQT
Relative Strength Index (RSI) 44.03 42.62
Support Level $0.33 $0.57
Resistance Level $0.77 $0.71
Average True Range (ATR) 0.05 0.10
MACD 0.01 -0.01
Stochastic Oscillator 63.10 24.24

Price Performance

Historical Comparison
PMCB
LIQT

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is renowned in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, Hybrid Technology Membranes and others. The Company operates through three reportable segments: Systems and Aftermarket, Filters and Membranes, and Components.

Share on Social Networks: